Biotech & Health
AI Is Starting to Reshape Clinical Trials
AI is being used to match patients, select trial sites, analyse clinical data and support drug development as AI-designed candidates reach later-stage trials.
5 articles
AI is being used to match patients, select trial sites, analyse clinical data and support drug development as AI-designed candidates reach later-stage trials.
AI biotech startup Enveda raises $311 million to advance nature-derived drug candidates into human clinical trials.
Moderna and Merck say their personalised mRNA cancer therapy met key Phase 3 goals in melanoma, reducing the risk of recurrence and distant metastasis.
Vivodyne opened a human biological data centre with 12 robotic HIVE labs designed to generate large-scale human tissue data for AI drug discovery research.
Triomics has raised $22 million in Series B funding to scale its oncology-focused AI platform that helps cancer centres streamline clinical workflows, patient data management, and trial…
Written by the reporters who cover each beat. Unsubscribe in one click.